Skip to Main Content

The Language of Difference: Increasing Equity and Inclusion in How We Categorize Patients

April 04, 2023
  • 00:02Well, welcome everyone to tonight's
  • 00:05webinar from the program from the
  • 00:08Yale Program for Biomedical Ethics.
  • 00:13I'm doctor Jack Hughes,
  • 00:15and I will be your host tonight.
  • 00:20I, along with my colleague Sarah Hall,
  • 00:22am an associate director of the
  • 00:26Program for Biomedical Ethics, our.
  • 00:32The our our usual host and the director
  • 00:36of the Program for Biomedical Ethics,
  • 00:39Doctor Mark Mercurio, is out of
  • 00:41town and will not be here tonight.
  • 00:44But we are pleased tonight to hear
  • 00:48from Professor Milger Cho from
  • 00:50Stanford University, who will talk to
  • 00:53us about the language of difference,
  • 00:56inclusiveness and equity. In the,
  • 01:02excuse me, increasing equity and
  • 01:06inclusion in how we categorize patients.
  • 01:10So before I introduce Doctor Cho,
  • 01:14I want to tell you,
  • 01:14I want to say a few words about
  • 01:17the program for biomedical ethics
  • 01:19and and also about how we're going
  • 01:22to conduct tonight's program.
  • 01:24The program for Biomedical Ethics,
  • 01:26as many of you are aware,
  • 01:28brings speakers on a variety of
  • 01:31topics in biomedical ethics on
  • 01:34at least once or twice a month.
  • 01:37And let me tell you about our
  • 01:42a couple of upcoming sessions,
  • 01:44one of which will be
  • 01:50let me see, I have it down here.
  • 01:54Yes, Professor Jen Miller from Yale
  • 01:56will be talking to us about equity and
  • 02:00biomedical research on April the 19th.
  • 02:05We will be sponsoring a day long
  • 02:09seminar on ethics of the heart justice
  • 02:13considerations in in heart failure.
  • 02:15That will be on May 11th and that is
  • 02:19organized by my colleague Dr. Sarah Fall.
  • 02:23So,
  • 02:26so in tonight's session,
  • 02:31Professor Cho will speak for approximately
  • 02:3745 minutes and after which she will
  • 02:42receive questions and comments.
  • 02:44Please put your your comments
  • 02:46and questions into the chat
  • 02:48function and I will read those to.
  • 02:52Professor Cho at the time. So
  • 02:59Professor Cho is professor of
  • 03:01Pediatrics and medicine at Stanford,
  • 03:04and she's the director of the Stanford
  • 03:07Center for Biomedical Ethics.
  • 03:09She's also the principal investigator of
  • 03:12the Stanford Center for Integration of
  • 03:16Research on Genetics and Ethics. And she is.
  • 03:24She is in addition to the director,
  • 03:29she's she is professor, and she is the
  • 03:38her major areas of interest are the ethical
  • 03:41and social issues raised by new technologies
  • 03:44such as genetic testing, gene therapy,
  • 03:47pharmacogenetics and gene patents.
  • 03:50She also studies how academic industry ties
  • 03:54affect the conduct of biomedical research.
  • 03:58She was an undergraduate at MIT,
  • 04:01obtained her PhD at Stanford.
  • 04:05And then did a health policy
  • 04:07fellowship at the University of
  • 04:08California at the San Francisco.
  • 04:10She has been at Stanford
  • 04:11for the past several years.
  • 04:13She is highly regarded as a mentor.
  • 04:16She is a productive author and researcher.
  • 04:20And we are delighted to have her
  • 04:23here tonight to talk to us about
  • 04:25the language of difference,
  • 04:26increasing equity and inclusion
  • 04:29in how we categorize patients.
  • 04:32Professor Cho.
  • 04:34It the the floor is yours.
  • 04:36Thank you very much.
  • 04:37Thank you. Thank you, doctor.
  • 04:57So thank you very much for inviting
  • 05:01me to join your group today.
  • 05:04I'm going to be talking a little bit
  • 05:06about the topic that I is not really
  • 05:09the focus of my main areas of research,
  • 05:11but it's one that I think is important to.
  • 05:18Addressed for bioethicists as well As for
  • 05:22biomedical scientists and clinicians. So
  • 05:32I hope you're able to see my slides here.
  • 05:40They look great. OK, good.
  • 05:47So what I'll be talking about today
  • 05:51stems from some work that I've
  • 05:54done on what we call DEI efforts,
  • 05:58diversity, equity and inclusion
  • 06:01efforts at Stanford and elsewhere.
  • 06:03And as many of you know,
  • 06:05these types of efforts are now
  • 06:08pervasive in biomedical research
  • 06:11at at medical institutions and.
  • 06:15Some of these efforts are aimed
  • 06:17at increasing diversity of human
  • 06:20participants in research as well
  • 06:22as in the research workforce.
  • 06:26The political and social forces
  • 06:28driving some of these efforts have been
  • 06:31comprehensively studied by sociologists
  • 06:33such as Steven Epstein and others,
  • 06:36but an under examined issue in DEI is the
  • 06:40language and the concept of human difference.
  • 06:43Not just as an exercise
  • 06:45in political correctness,
  • 06:47but in looking at DEI as an
  • 06:49ethical issue more broadly.
  • 06:51So what I hope to do is to show
  • 06:54why we need to critically examine
  • 06:56what we mean by diversity,
  • 06:58including how we measure it,
  • 07:00and that we must take care to ensure
  • 07:02that the language we use to concepts of
  • 07:07difference are scientifically accurate.
  • 07:10Clinically useful and not morally offensive.
  • 07:21So I'll argue that these
  • 07:24issues are ethical issues.
  • 07:26So what I'm showing you today is a part
  • 07:29of a national academies of sciences,
  • 07:32engineering and Medicine report on
  • 07:34the use of population descriptors in
  • 07:37genetics and genomics research that
  • 07:39was just released earlier this month.
  • 07:41And it provides recommendations for
  • 07:43the use of categories such as race,
  • 07:45ethnicity and ancestry,
  • 07:46which are built on a framework of
  • 07:49ethical principles which you can
  • 07:50see here in the middle of respect,
  • 07:53beneficence, equity and justice,
  • 07:56as well as scientific values of validity,
  • 07:59responsibility,
  • 07:59transparency and replicability.
  • 08:01So although this report was intended
  • 08:05for genetic research communities.
  • 08:08The principles apply to research
  • 08:10relevant to humans more generally,
  • 08:11and also to categories of human
  • 08:13difference other than race,
  • 08:15ethnicity, and ancestry.
  • 08:22So how I got started into
  • 08:24some of these issues,
  • 08:26looking at some of these issues,
  • 08:29was because of my role on.
  • 08:35On the editorial board of a journal
  • 08:37called Genetics and Medicine and
  • 08:40on a committee for this journal
  • 08:42that was called the Idea Committee,
  • 08:44the Inclusion, Diversity,
  • 08:46equity and Access Committee.
  • 08:48As chair of this committee,
  • 08:50the EDITORINCHIEF asked us to reexamine
  • 08:54the publications that have been put
  • 08:57out by the the journal over time.
  • 09:01For to look for possible offensive
  • 09:05terminology and to think about what
  • 09:07we should do about it as a journal.
  • 09:10And I know that many other journals,
  • 09:11professional societies,
  • 09:13publishers and others have
  • 09:15been doing similar things,
  • 09:18and in particular journals have been
  • 09:24out. Have been issuing guidelines
  • 09:26on language such as the American
  • 09:30Psychological Association which
  • 09:32you can see up on top has a style
  • 09:34guide and a major section of the
  • 09:36Style guide is called Bias free
  • 09:38language and it has very extensive
  • 09:41resources and recommendations for
  • 09:43the for language to be used in
  • 09:47publications of the society.
  • 09:50On the bottom right,
  • 09:52you can see that there have been
  • 09:54publications and guidance issued by
  • 09:57biomedical journals such as JAMA.
  • 09:59In particular,
  • 10:00this one was an updated guidance focusing
  • 10:03on reporting of race and ethnicity
  • 10:06in medical and science journals.
  • 10:08So what our journal was doing was
  • 10:10part of sort of a much larger movement.
  • 10:18So that was how it started, sort of.
  • 10:21Where we got to was publication
  • 10:23of an article called words Matter,
  • 10:26the language of difference in Human Genetics.
  • 10:28And I'll be telling you about that
  • 10:31paper through the rest of this talk.
  • 10:34And I want to acknowledge my
  • 10:35coauthors who some of whom are
  • 10:37members of the Idea Committee,
  • 10:39with me, in particular,
  • 10:41Laura du Galassio and, you know,
  • 10:44Laura du Galassio.
  • 10:46Who is also a molecular pathologist
  • 10:50and laboratory geneticist,
  • 10:52as well as Inna Amarillo,
  • 10:54who also runs a clinical genetics laboratory.
  • 10:57Kevin Mintz,
  • 10:57who is not a member of the committee
  • 11:00but Disability Rights Scholar who
  • 11:03also works on issues of disability
  • 11:06as they intersect with genetics.
  • 11:09Robin Bennett and Kyle Brothers,
  • 11:11who are members of the committee.
  • 11:13Robin is a genetic counselor.
  • 11:16Who has been working on guidelines for
  • 11:18terminology for the National Society of
  • 11:21Genetic Counselors for almost 30 years now,
  • 11:24and Kyle Brothers,
  • 11:25who is a pediatrician and also
  • 11:30an LC scholar who is works
  • 11:32on the committee with me.
  • 11:37So some of the premises of this paper are
  • 11:42that in biomedical research and medicine.
  • 11:45Language that defines the boundaries
  • 11:46of human difference is pervasive.
  • 11:48In fact, some of this language is critical,
  • 11:52and the concepts behind them are
  • 11:54critical to conducting biomedical
  • 11:56research and to clinical practice.
  • 12:01But the use of these categories
  • 12:04in research and clinical practice
  • 12:06does reify those boundaries.
  • 12:08And the classification schemes that
  • 12:11they imply confer power and privilege
  • 12:14to some and marginalize others,
  • 12:17which was very well described in the
  • 12:20seminal book by Jeff Bakker and Susan
  • 12:23Lee star called Sorting Things Out.
  • 12:27And these classification schemes can
  • 12:29also lead to poor health outcomes,
  • 12:37so. Let's ask ourselves some questions
  • 12:41about categorizing difference,
  • 12:43because these categories
  • 12:45do make a difference.
  • 12:47What do we mean by diversity?
  • 12:49Why do we classify according to certain
  • 12:52features of difference and not others?
  • 12:56An important part of biomedical
  • 12:59research and clinical practice
  • 13:00is creating and classifying.
  • 13:03According to these categories of difference,
  • 13:05in order to delineate,
  • 13:07delineate normal from abnormal,
  • 13:09pathogenic, from non pathogenic,
  • 13:11and other features which are necessary
  • 13:14to identify correlates of disease.
  • 13:17However, we know that classification
  • 13:19schemes privilege some, marginalize others,
  • 13:21and confer power and control to those
  • 13:25who devise the classification schemes.
  • 13:28So what I'll discuss today is why
  • 13:30it's important to ask questions about.
  • 13:32Why we are categorizing diversity and
  • 13:35how those categories are derived and why?
  • 13:38These are also ethical questions
  • 13:40and what I'm showing here is one
  • 13:46example of a categorization in the
  • 13:49international classifications of
  • 13:52diseases which has a category that is
  • 13:56called struck by Orca initial encounter.
  • 14:05So one major reason that the application
  • 14:08of the categories medically harmful for is,
  • 14:17for example, an example of how they can be
  • 14:20medically harmful is through the practice,
  • 14:23for example, of race norming or
  • 14:26that these categories can lead to
  • 14:29discrimination and access to services.
  • 14:32Another way these categories can be
  • 14:34harmful is if they're morally offensive by
  • 14:37reinforcing injustice and showing disrespect.
  • 14:40The categories in the labels used to
  • 14:42describe them are often value laden
  • 14:44and often assigned by people who not
  • 14:47do not belong to those categories.
  • 14:49Finally, when categories that are used
  • 14:51or derived from social or political
  • 14:54purposes are used in clinical practice or
  • 14:57biomedical research for different purposes,
  • 14:59they can be harmful
  • 15:01because they're inaccurate.
  • 15:02And lead to inappropriate aggregation
  • 15:04or disaggregation of data and
  • 15:07eventually health disparities.
  • 15:09I'll discuss several different
  • 15:11types of classification and the
  • 15:14language used to describe them,
  • 15:16including disability and severity of disease,
  • 15:20sex and gender, and race and ethnicity.
  • 15:23And I think this may be a good time to
  • 15:26give people a trigger warning that I will
  • 15:29be using terms that are considered slurs.
  • 15:31Throughout this talk,
  • 15:33because they're commonly used in
  • 15:35medical and scientific parlance today,
  • 15:38and it's necessary to identify them in
  • 15:40order to call them out as inappropriate
  • 15:43and also to present alternative language.
  • 15:45And I say this also knowing that from my
  • 15:50role as on the editorial board of a journal,
  • 15:52a scientific journal that every day.
  • 15:57I am asked to look at manuscripts
  • 15:59that are submitted to the journal that
  • 16:02still continue to use terminology
  • 16:04that are considered slurs.
  • 16:08So I think it's important to start
  • 16:11a conversation about educating,
  • 16:15educating various communities
  • 16:16about how and why these are
  • 16:19considered inappropriate now.
  • 16:26So let's start with the concept of disability
  • 16:29and looking at some definitions of it.
  • 16:32The first one is from the ADA,
  • 16:35which defines a person with a disability
  • 16:39as a person who has a physical or
  • 16:42mental impairment that substantially
  • 16:43limits one or more major life activity.
  • 16:47The second one comes from the CDC,
  • 16:48which defines disability as any
  • 16:50condition of the body or mind.
  • 16:53That makes it more difficult for
  • 16:54the person with the condition to
  • 16:56do certain activities and interact
  • 16:58with the world around them.
  • 17:00So you can perhaps imagine how these
  • 17:02definitions have an element of subjectivity,
  • 17:04but also that they focus on biological and
  • 17:08physical characteristics of individuals.
  • 17:15The Who published an international
  • 17:17classification of functioning,
  • 17:19disability and Health to give some
  • 17:21help to the concepts of function,
  • 17:23activity and participation levels,
  • 17:25and perhaps to reduce some subjectivity.
  • 17:29More importantly,
  • 17:30the ICF implicitly acknowledges the
  • 17:32role of environmental conditions in
  • 17:35essentially creating disability by raising
  • 17:38barriers to activity and participation.
  • 17:41Thus, it acknowledges that
  • 17:43disability is not just a biological
  • 17:45characteristic of an individual,
  • 17:46but includes a component of
  • 17:48interaction with the environment,
  • 17:50an idea that is central to
  • 17:51the disability critique.
  • 17:58So because biomedical researchers
  • 18:00play a big role in defining
  • 18:02categories of disability and disease,
  • 18:04and because these definitions
  • 18:06are value laden, it's the job.
  • 18:08Of researchers and bioethicists as
  • 18:11well to take a thoughtful approach
  • 18:14and guard against and combat ableism
  • 18:17in the act of classification.
  • 18:19Ableism is discrimination against
  • 18:21and stereotyping of whole groups of
  • 18:23people based on incorrect assumptions
  • 18:25that people with typical or normal
  • 18:28abilities are superior to those with
  • 18:30disabilities and that the disabled state
  • 18:33is undesirable and something to be fixed.
  • 18:37Unfortunately, ableist tendencies
  • 18:39are deeply embedded in our
  • 18:41society and in science as well.
  • 18:44Most of you have heard about the
  • 18:48$1927.00 versus Bell decision by
  • 18:51the US Supreme Court in which the
  • 18:54court upheld a Virginia statute that
  • 18:56provided for the sterilization for
  • 18:59of people considered genetically
  • 19:00unfit and paved the way for laws.
  • 19:04That were similar to that in 30 States
  • 19:06and leading to an estimated 65,000
  • 19:08Americans being sterilized without consent.
  • 19:12It's the categorization of Carrie
  • 19:14Buck as being genetically unfit
  • 19:18based on being labeled as
  • 19:21feebleminded and promiscuous
  • 19:24that was central to this case,
  • 19:27and this alleged promiscuity
  • 19:29led her to having a child.
  • 19:32And then the famous quote 3
  • 19:34generations of imbeciles are enough.
  • 19:39However, there was no evidence for
  • 19:42this family's feeblemindedness.
  • 19:44Carrie Buck was known to be an
  • 19:45avid reader of the newspaper,
  • 19:47and her school record in fact indicated
  • 19:49that she was not feebleminded.
  • 19:51Carrie's daughter Vivian was at
  • 19:53worst A/B student in school,
  • 19:55and even on the honor roll one year
  • 19:57Carrie's socalled promiscuity was actually.
  • 20:00The relabeling of her rape
  • 20:03by Clarence Garland,
  • 20:04a relative of her foster parents,
  • 20:07however, Harry Laughlin,
  • 20:08director of the Eugenics Record office
  • 20:10at Cold Spring Harbor Laboratory,
  • 20:11was the scientific expert who
  • 20:13nonetheless opined that Carrie Buck
  • 20:15should be sterilized based on the
  • 20:17assessment that she was feebleminded.
  • 20:19Those categorizations that were key
  • 20:21to allowing infringement of critical
  • 20:23individual rights and liberties
  • 20:25were absolutely not evidence based
  • 20:27and were but were protected by a
  • 20:30veneer of scientific authority.
  • 20:31While this Supreme Court case
  • 20:33perpetrated many moral injuries,
  • 20:35I think it's also an example,
  • 20:37albeit perhaps an extreme example,
  • 20:39of how categorization is misused
  • 20:41to great harm.
  • 20:48A different way that values are
  • 20:50embedded in categories is in the
  • 20:52terminology used to describe them.
  • 20:54Efforts by disability rights
  • 20:56groups and people with lived
  • 20:58experience with disabilities,
  • 20:59as well as their families,
  • 21:00have led the way towards greater
  • 21:03inclusivity of language to signal
  • 21:05respect and trustworthiness.
  • 21:06There's evidence that for
  • 21:08those with disabilities,
  • 21:09lack of inclusivity and respect are
  • 21:12ongoing barriers to receiving healthcare,
  • 21:15so these signals are more than symbolic.
  • 21:19Some specific actions that have
  • 21:21been taken include the passing of
  • 21:23Rosa's law in the United States,
  • 21:24which changes references to mental
  • 21:26retardation of federal law to
  • 21:28intellectual disability and changing
  • 21:30mentally ******** to individual
  • 21:32with an intellectual disability
  • 21:35taking a first person approach.
  • 21:37Families in the European fragile X
  • 21:41network have also recently led the
  • 21:44charge to rename the FM R1 gene.
  • 21:49To the fragile X messenger ribonuclear
  • 21:52ribonuclear protein 1 gene.
  • 21:56However,
  • 21:57in order to make good on the
  • 21:59principles of respect and beneficence,
  • 22:01it's important to look to disability
  • 22:04communities to understand when and
  • 22:06for whom taking the first person
  • 22:08approach is or is not preferred.
  • 22:10For example, many,
  • 22:11but not all individuals who are
  • 22:13deaf or who live with autism
  • 22:15spectrum disorder prefer being
  • 22:16referred to as deaf or autistic,
  • 22:18symbolizing that they consider
  • 22:20themselves part of a distinct cultural
  • 22:22group or have a distinct identity
  • 22:24on the basis of their disabilities.
  • 22:26However,
  • 22:27this begs the question about whether,
  • 22:29when,
  • 22:29and how researchers and
  • 22:31clinical professionals should be
  • 22:34categorizing conditions people for
  • 22:36research and clinical purposes.
  • 22:38And categories for new for scientific
  • 22:41purse should also be used for medical,
  • 22:43social policy and political purposes.
  • 22:50So moving on here to another example
  • 22:54of categorization of severity of
  • 22:58disease, I'll show you a recent
  • 23:02example which is the product
  • 23:04of value based decisions.
  • 23:06In this case, decisions made by
  • 23:08clinicians and criticized not only
  • 23:10for the categories themselves,
  • 23:11but for the process by
  • 23:14which they were generated.
  • 23:15So in this example,
  • 23:17I'm showing you here an article which
  • 23:21represents guidelines for carrier
  • 23:24genetic carrier screening issued by the
  • 23:27American College of Medical Genetics.
  • 23:30And these guidelines were meant to
  • 23:33address equitable distribution of
  • 23:34the benefits of genetic screening.
  • 23:36These guidelines expanded the
  • 23:38populations that were recommended to
  • 23:40get genetic screening for conditions
  • 23:42that are have been associated with
  • 23:47specific population subpopulation.
  • 23:50So prior to this update,
  • 23:53genetic screening guidelines
  • 23:54recommended that cystic fibrosis
  • 23:56screening be offered to those
  • 23:58of Northern European ancestry or
  • 24:00sickle cell disease be offered
  • 24:02to those of African ancestry,
  • 24:04for example.
  • 24:05So the update recognized that these
  • 24:08populations are not accurately
  • 24:09respective of who is likely to be
  • 24:12a carrier of the associated genes,
  • 24:14so the recommendations were no longer
  • 24:16limited to specific populations,
  • 24:20however well-intentioned,
  • 24:21these guidelines were criticized
  • 24:23in part because of how categories
  • 24:26of disease severity were
  • 24:28defined in these guidelines.
  • 24:31Disease severity is typically a key
  • 24:33factor in public health screening criteria,
  • 24:36as well as disease prevalence,
  • 24:38analytic validity,
  • 24:39availability of treatment for
  • 24:41diagnostic or reproductive options.
  • 24:47You can see some of the categories of
  • 24:50disease severity used in these guidelines
  • 24:52on the right side of the screen here,
  • 24:54including categories called profound,
  • 24:57severe, and moderate.
  • 25:01In a blog late last year,
  • 25:03the genetic counselors Katie Stoll
  • 25:05and Robert Resta highlighted the
  • 25:08categories of disease severity and
  • 25:11noted that it's concerning that
  • 25:13the study puts conditions that
  • 25:14are associated with intellectual
  • 25:16disability in the same group as
  • 25:18those that are associated with death
  • 25:20and infancy or early childhood.
  • 25:22Also, if we look across the lifespan.
  • 25:25Many if not most of us will experience
  • 25:28some features that could be counted
  • 25:31in the severe and or moderate buckets.
  • 25:34So importantly,
  • 25:34stolen Resta went on to critique how
  • 25:37the categories of disease severity
  • 25:40were just were actually derived being
  • 25:43based on a single limited survey of
  • 25:46healthcare providers that was conducted
  • 25:48by the company called Council,
  • 25:50now called Myriad Genetics because
  • 25:53they were bought by Myriad.
  • 25:56And this survey was limited to 192
  • 26:00genetic counselors and physicians,
  • 26:02and did not include those with lived
  • 26:04experience with the conditions
  • 26:05included on the ACMG panel.
  • 26:13So let's look at some recent examples
  • 26:15of changes to language describing
  • 26:17categories of sex and gender in
  • 26:20clinical documents, such as laboratory
  • 26:22requisition forms and reports.
  • 26:25Part of the rationale for these
  • 26:27suggested changes in language is
  • 26:29that the pathologization of these
  • 26:31characteristics and identities of
  • 26:33these groups adds to the stigma,
  • 26:35harassment, violence,
  • 26:36and healthcare inequities
  • 26:37these groups already face.
  • 26:39With very poor health outcomes
  • 26:41and leads to lack of trust in the
  • 26:43healthcare system as a whole.
  • 26:47These changes to category names
  • 26:49represent a major shift that's.
  • 26:51Can signal respect for gender and
  • 26:53sex and sex minority communities and
  • 26:56trustworthiness of healthcare providers,
  • 26:59but more work needs to be done to fully
  • 27:01and adopt inclusive language throughout
  • 27:03the research and healthcare enterprises.
  • 27:11Other medical professional groups
  • 27:13working with patient advocates have
  • 27:15also instituted changes to language
  • 27:17describing sex and gender minorities
  • 27:20to make categorization more expansive
  • 27:22and more inclusive of differences.
  • 27:24In particular, terms that imply
  • 27:26that only cisgendered individuals
  • 27:28are normal while others are
  • 27:30abnormal have been discontinued.
  • 27:32Again, this inclusivity is not just symbolic.
  • 27:35It facilitates the collection of clinically
  • 27:38relevant biological and social data,
  • 27:40as well as signaling respect,
  • 27:42trustworthiness and affirmation
  • 27:44of a diverse identity,
  • 27:46and conclude to increase clinic visits
  • 27:49and seeking access to care according to.
  • 27:54A large number of empirical
  • 27:56studies that have documented this.
  • 28:02There's another example from the
  • 28:03National Society of Genetic Counselors,
  • 28:05which last year changed its standardized
  • 28:08pedigree nomenclature in response
  • 28:10to quote a growing awareness of the
  • 28:13nonbinary nature of sex and gender,
  • 28:15as well as respect for the importance
  • 28:18in clinical settings of a person's
  • 28:21selfidentified gender and sexuality.
  • 28:23And this this article explicitly cites
  • 28:27evidence linking patients access to health
  • 28:31records with better health outcome.
  • 28:34You can see in this diagram.
  • 28:36Or maybe, maybe you can't,
  • 28:37but I hope you can see that there are
  • 28:40there's some new nomenclature symbols
  • 28:42which now includes a diamond shaped symbol
  • 28:46at the bottom row there in addition to
  • 28:49the previously used squares and circles.
  • 28:52And note that symbols represent
  • 28:54gender identity as opposed to
  • 28:56phenotypic gender and not sex.
  • 28:58The nomenclature also relies heavily on
  • 29:01annotation to add details of chromosome,
  • 29:03complement and family relationships
  • 29:05that are relevant to clinical
  • 29:07interpretation of the pedigree,
  • 29:09such as adoption, the use of donor gametes,
  • 29:12or gender affirming surgeries.
  • 29:16So this represents a major shift
  • 29:18and I think a move towards.
  • 29:21Both being more respectful
  • 29:23of patients identities,
  • 29:25but also seeking to be more
  • 29:29clinically and scientifically
  • 29:31accurate in capturing data in
  • 29:34and interactions with patients.
  • 29:41So move on to categories
  • 29:43of race and ethnicity.
  • 29:45Why do we use race and ethnicity
  • 29:47as categories in biomedical
  • 29:49research and clinical care?
  • 29:51In part, it's based on the assumption
  • 29:53that people of different races or
  • 29:56ancestries have different Physiology.
  • 29:58However, this is potentially dangerous.
  • 30:00It's led to practices such as race
  • 30:03norming that I mentioned before,
  • 30:05that have been criticized because of
  • 30:08their inaccuracy and the potential to
  • 30:10lead to under diagnosis and treatment,
  • 30:13or under under treatment or
  • 30:15withholding of benefits from
  • 30:17already disadvantaged groups.
  • 30:21Another example of how this can
  • 30:23be this thinking is dangerous is
  • 30:26from the infamous study based on
  • 30:29assumptions of differences between
  • 30:30blacks and whites in their Physiology
  • 30:33of response to infectious disease,
  • 30:35which you've probably heard of
  • 30:37the socalled Tuskegee study of
  • 30:39untreated syphilis in the ***** male.
  • 30:49But I and dozens of others have argued
  • 30:51that using social categories of race and
  • 30:53ethnicity are as proxies for biological
  • 30:55characteristics such as Physiology
  • 30:57or genetics or correlates of disease,
  • 31:00is extremely inexact at best,
  • 31:02and does not comport with evidence.
  • 31:05As a very simple example,
  • 31:08clinicians are taught to think of
  • 31:09sickle cell disease as a disease
  • 31:11of blacks or African Americans.
  • 31:13But the highest rates of sickle cell
  • 31:15disease are in some areas of Africa,
  • 31:17but also include India, Sicily,
  • 31:19Greece and southern Turkey.
  • 31:21And on the African continent,
  • 31:23the prevalence of sickle cell
  • 31:25trait in specific areas ranges
  • 31:27from less than 1% to 45%.
  • 31:29So typological thinking can be
  • 31:31very misleading when applied to
  • 31:34clinical care in some situations.
  • 31:42However, until very recently,
  • 31:44there's been little challenge
  • 31:46in biomedicine to the very idea
  • 31:48of the category of race itself.
  • 31:49For example, in its recently updated
  • 31:522021 guidance on the use of racial
  • 31:55and ethnic terms in publications,
  • 31:57JAMA recommended replacing the
  • 31:59term Caucasian with white.
  • 32:02Only stating that it quote is
  • 32:04technically specific to people from
  • 32:06the Caucasus region in Eurasia and
  • 32:09thus should not be used except when
  • 32:11referring to people from this region.
  • 32:14However, the guidance does not refer
  • 32:16to the fact that Caucasian was at one
  • 32:19point one of two categories of humans
  • 32:21that were and this the Caucasian
  • 32:23group was considered white skinned and
  • 32:25beautiful in contrast to the other
  • 32:28category that was considered Mongolian.
  • 32:30Who were devoid of virtue or later.
  • 32:34Caucasian was one of five
  • 32:36categories of human races which
  • 32:38represented God's original creation,
  • 32:40in contrast to the other four
  • 32:42which were considered degenerate
  • 32:44versions of the original human form,
  • 32:53so also in 2021.
  • 32:56My colleagues on the Idea Committee of
  • 32:59the Journal of Genetics and Medicine,
  • 33:01Kyle Brothers and Robin Bennett and
  • 33:03I proposed principles supporting
  • 33:05anti racism in publication of Human
  • 33:07Genetics and Genetics research
  • 33:09which were went a little further but
  • 33:13beyond previous recommendations.
  • 33:16And addressed appropriate and
  • 33:18inappropriate uses of entire categories
  • 33:21of race and genetic ancestry.
  • 33:23And you can see in a couple of the
  • 33:25principles out of the 8 principles
  • 33:27that we described in this article
  • 33:31that we tried to make distinctions
  • 33:34between the use of race as a social
  • 33:39political category and genetic
  • 33:43ancestry as well as ethnicity.
  • 33:55So the recent guidance of the
  • 33:57national academies that I mentioned
  • 33:59previously on the use of population
  • 34:01descriptors goes even further.
  • 34:03It's more specific,
  • 34:04outlining particular types of genetic
  • 34:08research and where categories of race,
  • 34:11ethnicity, ancestry,
  • 34:12indigeneity or geography should not be used
  • 34:16because they offer no scientific benefit,
  • 34:19yet can cause social harm,
  • 34:21this report cites.
  • 34:23Many tones of evidence of such harm,
  • 34:28and so it's.
  • 34:29I highly recommend reading it if you
  • 34:31would like to use it as such a resource,
  • 34:33but I'll also show you some some other
  • 34:37examples that we had described in our
  • 34:40article as well as in other venues.
  • 34:46So here is an example that shows the way
  • 34:49that shows that the way we group people
  • 34:52into categories shapes what we learn about
  • 34:54the groups and potentially causes harm.
  • 34:57In a retrospective analysis of over
  • 35:0085,000 patients tested for COVID-19
  • 35:02in the New York City Public Hospital
  • 35:05system in spring of 2020,
  • 35:07researchers analyzed COVID-19 outcomes of
  • 35:10Asian ethnic subgroups compared to Asians.
  • 35:13Overall, the.
  • 35:17And other racial groups shown
  • 35:19in in various colors here,
  • 35:22so I'm not telling you which
  • 35:24ones they are yet,
  • 35:25but the researchers found that there
  • 35:27were differences between groups
  • 35:29of patients classified as white,
  • 35:31black, Hispanic, and Asian.
  • 35:32But they also found that the
  • 35:35use of the Asian category masked
  • 35:38important differences in mortality.
  • 35:40So in this chart.
  • 35:42The group that was called White is
  • 35:45indicated here in orange on the left,
  • 35:49showing a larger number of negative
  • 35:53outcomes than the other groups shown
  • 35:56in green, yellow, purple, and blue,
  • 36:02and those other categories were
  • 36:06representing these other other groups.
  • 36:10Black, Hispanic and Asian
  • 36:13in purple, respectively.
  • 36:17But what's what is being shown in the
  • 36:21bar that is in red is the rates of
  • 36:24death in patients classified as Chinese,
  • 36:27which are included in the purple bar.
  • 36:30But when you separate them
  • 36:33out into their own category,
  • 36:35the death rates go up much higher.
  • 36:46In another example, a US study of
  • 36:49over 6 million patient records,
  • 36:52researchers found similar differences
  • 36:53between Asian subgroups and also
  • 36:55between Hispanic subgroups,
  • 36:57which included people who indicated
  • 36:59they were of Puerto Rican,
  • 37:01Mexican, Cuban, South American,
  • 37:03or Central American origin.
  • 37:06For example, they found that the
  • 37:08prevalence of chronic liver disease
  • 37:09was almost three times higher than.
  • 37:11For Mexican patients compared to
  • 37:13patients of Cuban ancestry, however,
  • 37:16there were also significant differences
  • 37:18based on whether you patients
  • 37:20were US born versus foreign born.
  • 37:22So cancer prevalence was twice as
  • 37:24high among those who were US born than
  • 37:26those who were born outside the US,
  • 37:28thus confirming the immigration paradox.
  • 37:31These studies,
  • 37:31and many others like them suggest
  • 37:33that race and ethnicity categories
  • 37:35can mask health differences.
  • 37:36And also indicate other variables,
  • 37:38such as immigration or socioeconomic status,
  • 37:41that might be more relevant but
  • 37:43often not collected or analyzed.
  • 37:46But does the routine routinized use
  • 37:48of entrenched categories distract
  • 37:50from the search for the most relevant
  • 37:52category for the most relevant categories?
  • 37:56So
  • 38:00here I'll switch to another example,
  • 38:02an old one, that shows how the entire
  • 38:05category of race is conceptually
  • 38:07bereft for scientific purposes.
  • 38:09In this case, because it's conflated
  • 38:11with ethnicity, intellectual ability,
  • 38:14and physical appearance.
  • 38:16So some of you may have may be familiar
  • 38:20with paper that was published in 1866,
  • 38:23the original paper describing
  • 38:26what is now called Down syndrome,
  • 38:29and in this paper Langdon proposed a
  • 38:33classification of the feebleminded.
  • 38:35By arranging them around
  • 38:37various ethnic standards,
  • 38:38and that's a quote in the paper.
  • 38:40And the paper goes on to say,
  • 38:42the number of idiots who arrange themselves
  • 38:45around the Mongolian type is so great,
  • 38:47and they present such a close resemblance
  • 38:49to one another in mental power,
  • 38:51that I shall describe an idiot
  • 38:53Member of this racial division.
  • 38:56So you can see the the conflation
  • 38:58of all these different concepts
  • 39:01here in these sentences.
  • 39:06In the 1950s, it was recognized
  • 39:08that this inaccurate conflation of
  • 39:10race with the condition associated
  • 39:12with variations of cognitive and
  • 39:14learning abilities was inappropriate
  • 39:15and led to the replacement of the
  • 39:18term ********* with Down syndrome.
  • 39:21Although this terminology arose centuries
  • 39:24ago and was also replaced decades ago,
  • 39:28it still persists in medical
  • 39:30terminology to the present day.
  • 39:33My my colleague Laura du Glazio alerted
  • 39:36me several months ago to the idea,
  • 39:38or to the fact that a quote from the
  • 39:41original Langdon down article was
  • 39:43very unproblematically presented in
  • 39:44the header of the entry for twice
  • 39:47semi 21 in the medical textbook
  • 39:49Smith's recognizable patterns of human
  • 39:52malformation in last year's edition,
  • 39:54which is the newest edition.
  • 39:57However, the underlying concepts
  • 39:59are harmful in healthcare,
  • 40:00especially when the categories they
  • 40:02represent are assumed to represent
  • 40:05clinical clinically relevant groupings.
  • 40:14Furthermore, the underlying
  • 40:15assumption of racial typologies is
  • 40:18delineating pure or distinct and non
  • 40:21overlapping groups also causes both
  • 40:23scientifical and ethical damage.
  • 40:25In this article, the authors call
  • 40:27out the category of multiracial.
  • 40:30Being used as the justification
  • 40:32for removing data relevant to
  • 40:34those individuals in the name of
  • 40:37quality control in a database,
  • 40:39which is a common practice.
  • 40:41This does unnecessarily unnecessary
  • 40:43violence to both the scientific
  • 40:46analysis and as well leaves out a
  • 40:49growing population from research.
  • 40:57So how should biomedical researchers?
  • 41:01And clinicians be more inclusive, respectful,
  • 41:04and accurate in their description and
  • 41:06categorization of human difference.
  • 41:08There are many ongoing efforts,
  • 41:10many of which I've mentioned here today,
  • 41:15with specific recommendations on language
  • 41:19study design and reporting in journals,
  • 41:21but also on considerations for
  • 41:24data collection and analysis.
  • 41:27I shows some of the recent.
  • 41:30Guidelines and resources here.
  • 41:32A common theme in these recommendations
  • 41:35about race and ethnicity is that
  • 41:37it should be not it should not
  • 41:39be used as biological variables,
  • 41:41but only as social variables, and that
  • 41:46how race and ethnicity are ascertained
  • 41:50should be accurately reported.
  • 41:52Importantly, why race and ethnicity is
  • 41:54used should be carefully considered
  • 41:56rather than done unquestionably.
  • 41:59You know, whether they or other
  • 42:01variables such as education,
  • 42:02economic status or environmental
  • 42:04factors are actually the most important
  • 42:07to answering the study question.
  • 42:10The National Academies report also talks
  • 42:13about transparency and reproducibility.
  • 42:16However, I also believe that
  • 42:19bioethicists have a role to play here,
  • 42:22as well as scientists.
  • 42:26The report also places responsibility
  • 42:28on research institutions and recommends
  • 42:30that they offer tools such as
  • 42:32educational modules for inclusion in
  • 42:34human research protection, training,
  • 42:36education and fostering interdisciplinary
  • 42:40collaborations between scientists and,
  • 42:43for example, sociologists,
  • 42:46anthropologists and others,
  • 42:47and for and with facilitating
  • 42:50community engagement,
  • 42:51among other things.
  • 42:55So I'll show I have some slides
  • 42:58here which have other resources for
  • 43:03recommendations on more inclusive
  • 43:07language here based on sex and gender
  • 43:12and on the next slide for disability.
  • 43:24So I'll just finish here
  • 43:27by raising some questions.
  • 43:32And to say that to make our research
  • 43:34more diverse, equitable and inclusive,
  • 43:36these are questions that researchers
  • 43:39and clinicians should ask about how
  • 43:41we are defining human difference.
  • 43:43So what is the evidence that racial,
  • 43:46ethnic, sex, gender,
  • 43:47or other differences are essential
  • 43:49to the research question and
  • 43:51relevant to clinical practice?
  • 43:53And are there other types of
  • 43:56difference that are being overlooked?
  • 43:58What's the evidence that the differences
  • 44:01are accurately measured or ascertained?
  • 44:03Is the validity of the classification
  • 44:06systems based on assumptions or evidence?
  • 44:09Are the category labels respective,
  • 44:12respectful, accurate, and derived
  • 44:14from or reflective of community input?
  • 44:18However, to the extent that
  • 44:20categorization and language should be
  • 44:22based on ethical principles of respect,
  • 44:24beneficence, and justice.
  • 44:26I submit that these are also questions
  • 44:30for the bioethics community as well.
  • 44:33I'll just leave you with a quote
  • 44:36from Paul Starr which I thought
  • 44:40was relevant to this
  • 44:44and it's from it's from some
  • 44:50writings that he he in which he.
  • 44:55Put forth the concept of cultural
  • 44:58authority and talk and spoke about
  • 45:02how clinicians can use this cultural,
  • 45:06cultural authority.
  • 45:07And he says here that patients consult
  • 45:10physicians not just for advice,
  • 45:12but first of all to find
  • 45:14out whether they are, quote,
  • 45:15really sick and what their symptoms mean.
  • 45:18Cultural authority in this
  • 45:20context is antecedent to action.
  • 45:22The authority to interpret
  • 45:24signs and symptoms,
  • 45:25to diagnose health or illness,
  • 45:27to name diseases,
  • 45:28and I emphasize that in bold myself,
  • 45:32and to offer prognosis,
  • 45:33is the foundation of any social
  • 45:36authority the physician can assume.
  • 45:38By shaping the patient's understanding
  • 45:40of their own experience,
  • 45:41physicians create the conditions under
  • 45:44which their advice seems appropriate.
  • 45:46And I thought that this quote
  • 45:48seemed appropriate for.
  • 45:49The issues that I hope we'll be
  • 45:52talking about further for the rest
  • 45:54of the for the rest of my time here.
  • 45:58All right,
  • 45:59wonderful. Thank you very much.
  • 46:03And I will at first before I throw the
  • 46:07session over for comments and questions,
  • 46:10I have to correct a couple
  • 46:12of statements I made earlier.
  • 46:13First of all, put your questions and
  • 46:17comments in the Q&A, not in the chat.
  • 46:21And second, the our next speaker,
  • 46:26Jen Miller will appear.
  • 46:28I don't I think I gave you the wrong date.
  • 46:30She will, she will be here on April the 12th.
  • 46:35So Doctor show, I want to ask what use
  • 46:40the prerogative of the chair or the
  • 46:43host to ask you do you have a sense of?
  • 46:48With all these journals revising
  • 46:52their policies,
  • 46:53do you have a sense of how effective
  • 46:58they've been or how well they've adhered
  • 47:03to their own their own guidelines?
  • 47:06And first of all,
  • 47:08it sounds like many journals have have
  • 47:11created their own sets of of guidelines.
  • 47:14Do you have a sense?
  • 47:15So I should.
  • 47:16Make this a two-part question.
  • 47:18What proportion of major journals
  • 47:20do you think have instituted these
  • 47:23kind of policies and second of all,
  • 47:25how successful have they been
  • 47:27in implementing those policies?
  • 47:33I don't know how many journals,
  • 47:35I haven't really looked specifically.
  • 47:37I know that the the JAMA guidelines
  • 47:39seem to be very influential,
  • 47:41as well as the APA style guidelines.
  • 47:44The APA has been working on those
  • 47:45style guidelines for a long time,
  • 47:47and they've added and and it's
  • 47:48sort of a living document,
  • 47:50so it's been revised.
  • 47:53In many ways over over the years.
  • 47:56So I think that other journals
  • 47:58defer to that those style guidelines
  • 48:00as as well as now to the the JAMA
  • 48:03guidelines which originally came
  • 48:04out many years ago and this up,
  • 48:06this latest update was
  • 48:08a significant revision.
  • 48:12But I know that you know,
  • 48:15having worked with some.
  • 48:17Genetics journals nearly 20
  • 48:19years ago where they did make
  • 48:21recommendations on the use
  • 48:23of terminology specifically
  • 48:24around race and ethnicity
  • 48:28that they know from their analysis after
  • 48:32the guidelines were released that there
  • 48:34was very little change in the publication,
  • 48:36so there is going to require more.
  • 48:45More concerted efforts at the level of,
  • 48:50you know, the editorial staff in
  • 48:53insisting on changes and 1st identifying
  • 48:56which changes need to be made,
  • 48:58which are not that easy. It's, you know,
  • 49:03it's it's very it requires very
  • 49:07close reading of of manuscripts to
  • 49:11understand some of these subtle,
  • 49:13subtle concepts.
  • 49:16So I think there's there was some hope,
  • 49:21I think I can speak for our journal,
  • 49:23that we were waiting to see what the
  • 49:26National Academies of Medicine had to say.
  • 49:28And indeed they have a whole section
  • 49:31of their report that is devoted to,
  • 49:38devoted to specific measures
  • 49:40that institutions should take.
  • 49:43To implement the recommendations
  • 49:46that that the academies have made.
  • 49:50So I think it's going to
  • 49:53require sort of multilayered,
  • 49:56multilevel efforts,
  • 49:58not just leaving it all to individual
  • 50:01researchers or or individuals at all,
  • 50:05and that institutions have to
  • 50:08provide resources for education.
  • 50:13And and and things like perhaps
  • 50:17things like prior institutional
  • 50:20review of publications to
  • 50:22help people by people who have
  • 50:25expertise in in in these areas
  • 50:32to help people individual
  • 50:34researchers who may not
  • 50:38have that kind of expertise.
  • 50:41You know, before everybody's educated
  • 50:43and on the same page about these types
  • 50:46of terminologies that are considered
  • 50:48acceptable and not acceptable,
  • 50:50that there's some resources that
  • 50:52are provided by institutions.
  • 50:55So you would put at least some
  • 50:57more of the burden on the
  • 51:00individual institutions and
  • 51:01therefore on the authors rather
  • 51:03than on the journals themselves,
  • 51:05which is understood.
  • 51:07The journals are certainly.
  • 51:09Sufficiently burdened but is
  • 51:11that am I interpreting your
  • 51:12your statement correctly.
  • 51:15So I think we have to kind of spread the
  • 51:18efforts out because it's going to take,
  • 51:21it's going to take this is a major
  • 51:23these are major changes that that are in
  • 51:25this report and that also that I think
  • 51:30it's not just about race and
  • 51:32ethnicity but other things you
  • 51:34know if you think about how.
  • 51:38You know laboratory reports are structured,
  • 51:42it's going to take some major,
  • 51:45major efforts to to align you know
  • 51:51all are the majority of clinical
  • 51:53laboratories so that they are they have
  • 51:56some kind of similarities in how they
  • 52:00are implementing inclusivity guidelines.
  • 52:06Thank you.
  • 52:08Now we have a what I consider a very
  • 52:11good question from our colleague Dr.
  • 52:13Chadi Tol Walker,
  • 52:14who says Stanford published a language
  • 52:17guide that was attacked and ridiculed
  • 52:20in the media and eventually taken down.
  • 52:23We at Yale and Doctor Tol Walker
  • 52:26was instrumental in this effort,
  • 52:28have developed an inclusive
  • 52:29language guide for our community.
  • 52:32Yale School of Medicine we have.
  • 52:34We have it behind a firewall so
  • 52:36that it's helpful to our community,
  • 52:38but would like to release it more widely.
  • 52:42Any tips for navigating potential criticism,
  • 52:45especially that made in bad faith?
  • 52:51Yeah, wow.
  • 52:54Yeah, this is quite the subject of many,
  • 52:56many faculty meetings, I think.
  • 53:06I'm not sure I have any really
  • 53:10effective tips for navigating criticism,
  • 53:12but I do think that it it may be helpful to
  • 53:21to provide more scaffolding so rather
  • 53:25than just releasing a document.
  • 53:28Which has no context, which doesn't
  • 53:30have sort of the opportunity for
  • 53:32discussion and explanation and
  • 53:38providing context
  • 53:42that it may be more helpful to have
  • 53:50have the document be discussed
  • 53:52it with the sort of in the
  • 53:55environment of a more interactive.
  • 53:58You know educational setting probably
  • 54:02multiple educational settings.
  • 54:04So that because these are
  • 54:07pretty nuanced issues and
  • 54:11and I think that's something that's
  • 54:13an issue that was faced by these
  • 54:15journals that we're putting out language
  • 54:17guidelines is because you can't really.
  • 54:19It's very hard to make sort of blanket
  • 54:21statements about how you should use certain
  • 54:23words and and not and you could see that
  • 54:25in the National Academies report where.
  • 54:27You know you can't make a rule
  • 54:29and say you can't use race ever,
  • 54:31because sometimes it you actually
  • 54:33should be using race.
  • 54:34For example, you can't study end of.
  • 54:37So for example,
  • 54:38the very reason why the government
  • 54:41came up with the O MB categories
  • 54:44of race and ethnicity back in the
  • 54:4770s was in response to and so they
  • 54:50could in order to make it possible
  • 54:52to measure discrimination.
  • 54:54And so you can't measure discrimination
  • 54:56without social categories of race.
  • 54:58So the problem comes in is when
  • 55:01you're using categories that are
  • 55:02mismatched with the uses, right?
  • 55:04So if you're trying to capture biological,
  • 55:08biological features and you're
  • 55:10using social categories to do that,
  • 55:12you're, you're,
  • 55:13you're really going to have problems there.
  • 55:16And that's where.
  • 55:18But those are kind of nuanced
  • 55:20issues that you can't really just.
  • 55:21It's hard to just sort of make
  • 55:24guidelines about and and also to to
  • 55:27explain I think you know there are
  • 55:30certain terms where it seems more
  • 55:32obvious than others why they're
  • 55:35considered offensive now but you'd
  • 55:37be surprised.
  • 55:38Some people really have no you know
  • 55:41especially when you know a place
  • 55:43like Yale or less like Stanford
  • 55:45which has people coming from.
  • 55:47A wide variety of cultures globally
  • 55:50and different traditions and practices.
  • 55:55You know, I think it it it means that
  • 55:58these discussions have to give people
  • 56:00space to ask questions and not feel like
  • 56:03they're being criticized for asking
  • 56:05questions because they don't understand.
  • 56:09Thank you. I I will say that the
  • 56:11that the Yale document actually it
  • 56:14does attempt and I think it does
  • 56:17reasonably well to provide context
  • 56:20and to provide explanations the the
  • 56:24the question and I can certainly
  • 56:27understand the concern is that how,
  • 56:30how are we going to get people to pay
  • 56:33attention to the document and to actually.
  • 56:37Incorporate the the context and the
  • 56:41explanations and the history all of
  • 56:44which is in there in a in a fairly
  • 56:46succinct form but I think but it's
  • 56:49it's a very nice job so far but yeah
  • 56:53I'd love to see it actually sounds very
  • 56:55well we will we will send
  • 56:58it along absolutely.
  • 56:59So that's that's that's very helpful.
  • 57:03I I have to apologize once again.
  • 57:06Apparently I have screwed up my,
  • 57:09my, my dates so that I I this
  • 57:14will take just a moment.
  • 57:16But I said that doctor Doctor Miller
  • 57:20would be appearing on April the 12th
  • 57:23and it looks like she's actually
  • 57:26going to be here on April the 19th.
  • 57:28The Cardiology Ethics Symposium
  • 57:30will be on Friday, may the 11th.
  • 57:33It will be on Friday,
  • 57:34may the 12th and that will be an all day
  • 57:37session on the ethics of heart failure.
  • 57:40So let let me proceed.
  • 57:47Okay, so here's a a question from
  • 57:50an anonymous attendee how can I I,
  • 57:52a student at the Yale PA program
  • 57:54physician associate program,
  • 57:56enlist the help of the biomedical
  • 57:59ethics department to ensure the legacy
  • 58:03of unscientific categorizations at at
  • 58:05Yale ends in our medical Ed curriculum?
  • 58:09I have seen outdated genetics terminology,
  • 58:13outdated guidelines,
  • 58:15suggestions regarding regarding
  • 58:17ACE inhibitors in black patients,
  • 58:20and incorrect terms used for describing
  • 58:24geographic anxiety and population difference.
  • 58:27How do I enlist your help to
  • 58:31update our curriculum so?
  • 58:34This is, this is obviously a
  • 58:36problem we have to deal with here,
  • 58:39but do you have some
  • 58:42suggestions for our students?
  • 58:45Yeah, great question. Yes.
  • 58:49I mean if if you were at Stanford,
  • 58:51what would I tell you? I would say,
  • 58:56you know, probably similarly at Yale
  • 59:00there are now sort of a plethora of.
  • 59:04Committees that are dealing with DEI
  • 59:08or Jedi or idea or whatever acronym
  • 59:12they want to use that are supposed
  • 59:16to be dealing with these issues.
  • 59:18And I would imagine there is a
  • 59:22curriculum committee that is thinking
  • 59:25about how to make the curriculum more
  • 59:29inclusive and improve it in many ways.
  • 59:32In terms of all kinds of related
  • 59:37features or characteristics.
  • 59:39So that's where I would go and to,
  • 59:44you know, raise, raise these,
  • 59:46these issues,
  • 59:47I imagine that there are also
  • 59:53efforts at the national level and I
  • 59:57know that the one of the recommendations
  • 60:00from the National Academies report.
  • 01:00:02Was to form a clearinghouse of resources
  • 01:00:08and also of you know guidelines and
  • 01:00:12and that sort of thing, but also of
  • 01:00:18things like curriculum changes and and
  • 01:00:21educational modules that are being developed.
  • 01:00:25So sort of a sharing, a locus of
  • 01:00:29sharing of these kinds of materials.
  • 01:00:32Although that's that report was just issued,
  • 01:00:34I don't know of any such body right now,
  • 01:00:39but I imagine that there
  • 01:00:42will be some movement in that
  • 01:00:44direction may be led by you know,
  • 01:00:47a group like the double AMC, right,
  • 01:00:49the American Academy of Medical Colleges,
  • 01:00:54right. And I would add that we
  • 01:00:57certainly have a structure.
  • 01:01:00That is meant to deal with DEI here
  • 01:01:03on the medical school campus and that
  • 01:01:06should apply to the PA program as well.
  • 01:01:09So and if that should be an Ave.
  • 01:01:14for redress and if it's not,
  • 01:01:17we have work to do. So thank you.
  • 01:01:22Another question.
  • 01:01:25Some people express frustration
  • 01:01:27at the imperative to use precise
  • 01:01:29language due to the perception that it
  • 01:01:32changes so quickly and so frequently.
  • 01:01:34Of course, the nature of language is
  • 01:01:36that it is always changing and evolving,
  • 01:01:39but this is some people's concern.
  • 01:01:43Can you speak a bit more to this point?
  • 01:01:48This is an issue that I talked about
  • 01:01:50with my coauthors of the paper,
  • 01:01:51knowing that as soon as it was
  • 01:01:53published it was going to be outdated.
  • 01:01:55But I think how we dealt with
  • 01:01:58that or tried to reconcile this,
  • 01:02:04you know, with our own
  • 01:02:06publication, was that the act of
  • 01:02:15keeping up with sort of. The the
  • 01:02:20Times in terms of understanding
  • 01:02:24both where language and categorization
  • 01:02:29are doing scientific and clinical
  • 01:02:33damage and and also where it is doing
  • 01:02:40causing causing disrespect
  • 01:02:45of various communities.
  • 01:02:47Just the very act of of doing that
  • 01:02:52is in itself a virtuous activity,
  • 01:02:56so signaling trustworthiness and signaling
  • 01:03:02open mindedness.
  • 01:03:04And to some extent I think
  • 01:03:07part of the frustration is
  • 01:03:11due to the underlying sort of.
  • 01:03:15Movement that is happening here,
  • 01:03:17which is that it means sort of
  • 01:03:22admitting that professional groups
  • 01:03:25may not be the ones in power
  • 01:03:29anymore and with the authority
  • 01:03:32to make these decisions and and
  • 01:03:35that some of that power has to be
  • 01:03:38ceded to communities and patients,
  • 01:03:44so. And so that means I think that this is,
  • 01:03:50this is even though the language is changing
  • 01:03:52and evolving and that's frustrating.
  • 01:03:53I think the there's a bigger thing that's
  • 01:03:57evolving underneath that fundamentally,
  • 01:03:58which is a power shift.
  • 01:04:04Thank you. Very good.
  • 01:04:07I would like to just.
  • 01:04:14Read a response from Doctor Paul Walker.
  • 01:04:16He says thank you. That's how we're
  • 01:04:19using it internally right now,
  • 01:04:21contextualizing narrow educational
  • 01:04:23slash research slash clinical
  • 01:04:25settings to foster conversation.
  • 01:04:28I've read some bad faith out of
  • 01:04:32context criticism of the Stanford
  • 01:04:34guy that I suspect deliberately
  • 01:04:36ignored the context in the
  • 01:04:38interest of sensationalism is that.
  • 01:04:42Do you think that's the case or yeah,
  • 01:04:45I I think that's that's true.
  • 01:04:48But I think it does point out that
  • 01:04:53even guidelines like this on language use
  • 01:04:58are highly and should be highly contextual,
  • 01:05:02right? I mean, you can use the exact
  • 01:05:05same word in different setting. Right.
  • 01:05:07And we're talking about usage in research,
  • 01:05:10usage in patient doctor communications,
  • 01:05:13in publications in the news in, you know,
  • 01:05:17all these different settings and the exact
  • 01:05:19same term can have different meanings
  • 01:05:21in those different settings, right. So
  • 01:05:26not to say that the criticism was,
  • 01:05:30you know, I think the criticism was
  • 01:05:32really in the interest of sensationalism
  • 01:05:35as as as you mentioned and.
  • 01:05:41But I think it is. That's why I think
  • 01:05:44it's important to provide these types
  • 01:05:47of recommendations in the with a very
  • 01:05:51clear context alongside it. Well,
  • 01:05:56I'm going to speculate that some
  • 01:05:58of the some of the criticisms that.
  • 01:06:01We we we might say we're not
  • 01:06:05particularly reasoned or balanced
  • 01:06:07or thoughtful perhaps. All right.
  • 01:06:10We're part of a understandably
  • 01:06:12human reaction to change.
  • 01:06:14We don't like change.
  • 01:06:16We don't like being even having
  • 01:06:19it implied that we've been
  • 01:06:20incorrect in what we've been
  • 01:06:22doing for load these many years.
  • 01:06:24And so I
  • 01:06:28I, I sort of under, I think I understand.
  • 01:06:32I when I've been, when when it's
  • 01:06:34been brought to my own attention of
  • 01:06:36something that I had not even considered.
  • 01:06:39And my first reaction is defensive.
  • 01:06:42And I want to, I want to argue.
  • 01:06:46But but I have.
  • 01:06:48I'm fortunately surrounded by colleagues
  • 01:06:51who are are fair thinkers and reasonable
  • 01:06:54people and have a calming influence.
  • 01:06:56But so I I think I understand how.
  • 01:07:00These, these reactions are
  • 01:07:03generated and I wonder if it's not
  • 01:07:05to a certain extent inevitable.
  • 01:07:08And I guess that's what we're
  • 01:07:10trying to minimize with all of this.
  • 01:07:12I think it's also important that as part
  • 01:07:14of the educational process that we've
  • 01:07:16been talking about, and I'm sure that
  • 01:07:21doctor tall Walker is, is is
  • 01:07:24using these guidelines for that.
  • 01:07:27You know, it's part of what can
  • 01:07:30be helpful here I think is,
  • 01:07:35you know, an understanding of how
  • 01:07:38the language is not just, you know,
  • 01:07:43it's not just political correctness that the
  • 01:07:46language use has clinical impacts, right.
  • 01:07:49And it has, it can have very
  • 01:07:52negative clinical impacts and so.
  • 01:07:54Part of what we tried to do in our paper
  • 01:07:56is sort of cite some of the evidence,
  • 01:07:57but we couldn't really cite all of it.
  • 01:07:59But there is a lot of evidence out
  • 01:08:02there that shows how that makes
  • 01:08:04connections between language and
  • 01:08:06categorization and actual harms.
  • 01:08:08So I think that's important to convey that
  • 01:08:11this isn't just sort of like an empty,
  • 01:08:15you know, empty cry of wokeness, right?
  • 01:08:18That there's actual people get hurt.
  • 01:08:23Yes. And and it seems to me that when you,
  • 01:08:27when you when you're able to provide
  • 01:08:29examples they can be really compelling.
  • 01:08:31Some of the examples you provided in
  • 01:08:33in your talk just just now I think
  • 01:08:37could be could be really compelling
  • 01:08:39and maybe it it has something maybe
  • 01:08:42the strategy has to be that it has
  • 01:08:45to be introducing small amounts
  • 01:08:48with very compelling narratives.
  • 01:08:52In order to tone down these reactions,
  • 01:08:57but I'm just speculating,
  • 01:09:01Dr. Tall Walker has a further
  • 01:09:04contribution to the PA student. The.
  • 01:09:08And I will try, if I can figure it out,
  • 01:09:10I'll try to figure out how to put
  • 01:09:12this into the chat or the Q&A.
  • 01:09:14It's well actually if you look in the
  • 01:09:18Q&A, m.yale.ed U slash language and
  • 01:09:22that's the website that the student
  • 01:09:23can bring up to the PA curriculum group
  • 01:09:26to help forward the conversation.
  • 01:09:28So that's our local local problem here.
  • 01:09:33Another question from our faculty.
  • 01:09:39Hold on. In response to the question
  • 01:09:42of how to deal with teaching faculty
  • 01:09:45using inappropriate language,
  • 01:09:47I would say the course directors
  • 01:09:49try very hard to address these
  • 01:09:51issues with individual faculty and
  • 01:09:53also provide them with resources
  • 01:09:55to update the language they use.
  • 01:09:57So I agree. I think, I think we're,
  • 01:10:01we're working on this, we're,
  • 01:10:03we're trying to do better. So.
  • 01:10:08And and and so my
  • 01:10:14as part of what we've been been
  • 01:10:18talking about this this whole idea of
  • 01:10:22you know can you think of of the the
  • 01:10:27larger strategy for how we implement
  • 01:10:30these suggestions these these changes.
  • 01:10:37Through academic medicine,
  • 01:10:38but through medicine in general.
  • 01:10:40And that's a very large question and I
  • 01:10:42think you've partially addressed it so far.
  • 01:10:44But if you have any thoughts about the,
  • 01:10:47the grand strategy, if if you will.
  • 01:10:53Yeah, I haven't really thought that
  • 01:10:55much about sort of broader changes,
  • 01:10:57how to sort of implement broader changes
  • 01:11:00in medicine writ large that that's huge.
  • 01:11:04I mean, obviously education.
  • 01:11:06And the medical education process is,
  • 01:11:09is is you know, an obvious target of efforts
  • 01:11:19and there are I think there are some
  • 01:11:23some resources that are aimed at sort
  • 01:11:25of in the growing set of resources.
  • 01:11:27I'm sorry I don't have them sort of
  • 01:11:30off the tip of my tongue right now,
  • 01:11:33but there are resources on sort of.
  • 01:11:39For example, anti racism and
  • 01:11:42anti ableism in medicine,
  • 01:11:44how to institutionalize those,
  • 01:11:50you know, that's that's a
  • 01:11:51different story. I think
  • 01:11:55in terms of research there
  • 01:11:58are some leverage points.
  • 01:12:00Some of which are mentioned in
  • 01:12:02that National Academies report.
  • 01:12:03And although the report really
  • 01:12:05is focused on race and ethnicity,
  • 01:12:07I think these leverage points are
  • 01:12:10really valid for all research.
  • 01:12:13So one of them is obviously
  • 01:12:15through journal publication.
  • 01:12:18Another one that they pointed
  • 01:12:20to is research funders,
  • 01:12:21and they provide a even a sort
  • 01:12:25of checklist of things that
  • 01:12:27research funders should ask.
  • 01:12:29Before they provide funding to
  • 01:12:32researchers to assure that they have
  • 01:12:35gotten education on issues regarding racism,
  • 01:12:40ableism, etcetera,
  • 01:12:45as well as. Pretty specific
  • 01:12:47questions they could be asking.
  • 01:12:50Funders could be asking of researchers
  • 01:12:53in in their in Grant proposal right
  • 01:12:57in terms of study design and asking
  • 01:13:00for methodological rigor in in
  • 01:13:04their use and and even questioning.
  • 01:13:07Do you need to use categories
  • 01:13:09such as race altogether?
  • 01:13:11Maybe you don't.
  • 01:13:12Maybe it would be inappropriate.
  • 01:13:16So there's there's lots of sort of
  • 01:13:19levers that can be pushed there and
  • 01:13:22and that there's institutionally some
  • 01:13:24of the things they talked about were
  • 01:13:28at the level of the IRB for example and
  • 01:13:34you know although that might end up by.
  • 01:13:40In the form of more requirements
  • 01:13:43for training, like HIPAA training,
  • 01:13:45you know, but that is one of
  • 01:13:48the suggestions that they made.
  • 01:13:50And, you know, requiring that
  • 01:13:52there be some education before
  • 01:13:55researchers are allowed to use
  • 01:13:58samples from human subjects,
  • 01:14:00or to access human subjects
  • 01:14:02at all in their research.
  • 01:14:09They also talked about
  • 01:14:15I think there were there were other
  • 01:14:17issues that were really institutional
  • 01:14:21beyond education but you know there's
  • 01:14:24there's sort of many different places
  • 01:14:26pressure points that that where
  • 01:14:32faculty for example at
  • 01:14:34academic organizations.
  • 01:14:39You know are are subject to pressure
  • 01:14:42from from the institution and and the
  • 01:14:46institution and can have requirements.
  • 01:14:50The other one that I mentioned
  • 01:14:52was you know review of protocols
  • 01:14:54for example or maybe of articles
  • 01:14:57and obviously they're these are
  • 01:14:59probably going to come up against.
  • 01:15:05Criticisms in terms of academic
  • 01:15:07freedom and and so forth.
  • 01:15:09But I think that there are
  • 01:15:13some good ethical reasons why,
  • 01:15:16at the very least,
  • 01:15:19researchers should be asked
  • 01:15:22to demonstrate some type of
  • 01:15:24competency and knowledge about
  • 01:15:29the use of categories for scientific reasons.
  • 01:15:33I think that you know.
  • 01:15:35The way that we use the categories
  • 01:15:38of human difference that are related
  • 01:15:40to social identities are used in ways
  • 01:15:44that are very methodologically sloppy,
  • 01:15:47and we would not allow other medical
  • 01:15:51variables to be used in this way,
  • 01:15:53right, if you think about when
  • 01:15:55you're making measurements.
  • 01:15:56Of things are certain things that are
  • 01:15:58related to rigor and reproducibility.
  • 01:16:00You know, when you measure a blood pressure,
  • 01:16:02you need to know it's a blood pressure.
  • 01:16:04And what is blood pressure?
  • 01:16:06You have to have definitions of that,
  • 01:16:09you know, and we don't treat these
  • 01:16:11identity categories or these social
  • 01:16:13categories in the same way at all.
  • 01:16:17So you know, that's another,
  • 01:16:19that's another issue.
  • 01:16:23And then finally one of the things that.
  • 01:16:25I've been talking about is including
  • 01:16:29these issues in analysis of research
  • 01:16:35ethics consultation cases. So
  • 01:16:41I have a long list of things that
  • 01:16:43I am now requiring our trainees
  • 01:16:46who are trained getting training
  • 01:16:48and research ethics consultation
  • 01:16:50to read so that they can include
  • 01:16:52these considerations as their.
  • 01:16:54Reviewing protocols or study designs
  • 01:16:58that are presented in the context
  • 01:17:00of research ethics consultation.
  • 01:17:05The the,
  • 01:17:08the idea, or the the notion of
  • 01:17:11requiring people to demonstrate some
  • 01:17:14confidence in these matters before
  • 01:17:17they can participate in in submitting
  • 01:17:20research or submitting documents.
  • 01:17:24Do you I I assume that runs the risk
  • 01:17:27of generating resentment and people at,
  • 01:17:31you know, doing the functory checklist,
  • 01:17:34learning as little as possible to get
  • 01:17:38by through the process of getting their
  • 01:17:41grants submitted and funded and getting
  • 01:17:45their documents reviewed and accepted.
  • 01:17:48But, and that troubles me to an extent, but.
  • 01:17:52On the other hand, once people understand
  • 01:17:56what the what's the, what's required,
  • 01:18:02we seem to adapt and it becomes
  • 01:18:06part of part of what life is about.
  • 01:18:09And so this would be part of what
  • 01:18:11academic life would be about.
  • 01:18:13Perhaps eventually we get to where this is
  • 01:18:15part of what clinical practice is all about.
  • 01:18:19And so maybe, at least initially,
  • 01:18:22we don't care if people believe avidly in
  • 01:18:25all the things that you've been advocating,
  • 01:18:30but at least they can fake
  • 01:18:32it until they make it.
  • 01:18:34Now, does that sound just too cynical,
  • 01:18:36or is is that a possible approach?
  • 01:18:42Well, yeah, I think.
  • 01:18:44Yeah, for some people they're, you know,
  • 01:18:46these practices are very entrenched.
  • 01:18:48When, you know,
  • 01:18:49when somebody does a case presentation,
  • 01:18:51what they, what do they start with?
  • 01:18:52They start with, you know,
  • 01:18:54this is a 35 year old black male with blah,
  • 01:18:57blah, blah, blah blah.
  • 01:18:58And without any sort of thought about,
  • 01:19:00well, what is that?
  • 01:19:01Why is that relevant?
  • 01:19:02Is that relevant at all in this case,
  • 01:19:04what does black mean?
  • 01:19:05I mean that the National Academy
  • 01:19:07report actually recommends not
  • 01:19:09using the term black anymore.
  • 01:19:11It also recommends not using
  • 01:19:13the term white anymore because
  • 01:19:15what does that even mean?
  • 01:19:16What does that even mean in the context of,
  • 01:19:19you know,
  • 01:19:24well, I mean, we could go on for
  • 01:19:25hours just about that question in
  • 01:19:27and of itself, but we do a lot of
  • 01:19:30things without thinking, right?
  • 01:19:32And so I think just asking
  • 01:19:34people to pause for a moment.
  • 01:19:43And if that means that there has to
  • 01:19:46be sort of educational requirements,
  • 01:19:54you know, I think those are
  • 01:19:56going to cause resentment,
  • 01:19:57but also once if these kinds of issues
  • 01:20:04get incorporated at levels like.
  • 01:20:08At places like in the grant review process,
  • 01:20:12in the paper review process,
  • 01:20:16that means that they will be
  • 01:20:18inevitable and people will have to
  • 01:20:23do more than fake it.
  • 01:20:27They they can't just talk to talk,
  • 01:20:30they have to be.
  • 01:20:31Eventually they will walk the walk,
  • 01:20:34as you said in some circles.
  • 01:20:37Well, this has been a
  • 01:20:41delightful session and we really
  • 01:20:44appreciate you joining us.
  • 01:20:46Do you have any further remarks
  • 01:20:49you'd like to conclude with?
  • 01:20:55I don't think so.
  • 01:20:58Just want to thank you for
  • 01:21:01inviting me to see your group,
  • 01:21:03even though I can't really see them.
  • 01:21:05Yes, all right. Well,
  • 01:21:06thank you so much. This has been,
  • 01:21:09this has been terrific and we really
  • 01:21:11appreciate you you joining us.
  • 01:21:13So have have a good evening.
  • 01:21:16Thank you.